ALPCO provide a broad portfolio of life science research tools for academic, pre-clinical and clinical use, including primary antibodies, flow cytometry reagents, recombinant proteins, and products for HPLC and LC-MS/MS, but are best known for providing, as they put it: “Immunoassays Beyond the Ordinary.”
ALPCO have a reputation for quality among their customers because they focus on providing immunoassays which are highly sensitive, specific and reproducible with a broad dynamic range that allows for fewer dilution steps and therefore reduced systematic error.
They have recently developed the new STELLUX™ range of chemiluminescent immunosorbent assays. These combine exquisite sensitivity, ease of use, and outstanding reliability which comes from extensive testing and characterisation.
Their products cover nine therapeutic areas:
- Bone Metabolism
- CVD & Oxidative Stress
- Diabetes & Obesity
Allergy & Infectious disease
Biomarkers for Diabetes & Obesity
Energy homeostasis is a well-regulated process that depends on the coordination between feeding behaviour and energy expenditure. The control of energy homeostasis in humans has received much attention in recent years due to alterations caused by the onset of conditions such as obesity and diabetes. ALPCO offers numerous assay kits to assist both academic and industry researchers with quantification of analytes associated with energy homeostasis.
Related articles to each of the listed products are availble to read by following the 'Find Out More' links.
- Human Total Adiponectin ELISA Find Out More
- Human Multimeric Adiponectin ELISA Find Out More
- Mouse HMW & Total Adiponectin ELISA Find Out More
- Human Leptin ELISA
- GLP-1 ELISA (Active 7-36)
- Total GLP-1 ELISA (7-36 and 9-36)
- Peptide YY ELISA (PYY ELISA)
- Acylated Ghrelin ELISA
- Non-Acylated Ghrelin ELISA
- Insulin ELISAs Find Out More
- C-Peptide ELISAs
- Proinsulin ELISAs Find Out More
As we continue to gain a better understanding of the intricacies of bone metabolism and the key regulators involved, we may gain further insights into mechanisms underlying other bone-related diseases as well. ALPCO’s portfolio of bone metabolism assays serves as a powerful tool for studying bone-related pathologies and may help guide the development of new, targeted therapeutics.
Find Out More
Bioamines & Neuroscience
Cardiovascular Disease and Oxidative Stress
Cytokines and Cell Signaling
Diabetes and Obesity
Antibodies and Antigens